These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29100389)

  • 1. Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.
    Ziouziou H; Andrieu C; Laurini E; Karaki S; Fermeglia M; Oueslati R; Taieb D; Camplo M; Siri O; Pricl S; Katsogiannou M; Rocchi P
    Oncotarget; 2017 Sep; 8(44):77317-77329. PubMed ID: 29100389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.
    Andrieu C; Taieb D; Baylot V; Ettinger S; Soubeyran P; De-Thonel A; Nelson C; Garrido C; So A; Fazli L; Bladou F; Gleave M; Iovanna JL; Rocchi P
    Oncogene; 2010 Apr; 29(13):1883-96. PubMed ID: 20101233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer.
    Ziouziou H; Paris C; Benizri S; Le TK; Andrieu C; Nguyen DT; Appavoo A; Taïeb D; Brunel F; Oueslati R; Siri O; Camplo M; Barthélémy P; Rocchi P
    Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33925528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
    Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
    Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.
    Ziouziou H; Andrieu C; Laurini E; Karaki S; Fermeglia M; Oueslati R; Taieb D; Camplo M; Siri O; Pricl S; Katsogiannou M; Rocchi P
    Oncotarget; 2018 Jun; 9(47):28797. PubMed ID: 29983898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond simple castration: targeting the molecular basis of treatment resistance in advanced prostate cancer.
    Gleave M; Miyake H; Chi K
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():47-57. PubMed ID: 16273354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.
    D'Abronzo LS; Bose S; Crapuchettes ME; Beggs RE; Vinall RL; Tepper CG; Siddiqui S; Mudryj M; Melgoza FU; Durbin-Johnson BP; deVere White RW; Ghosh PM
    Oncogene; 2017 Nov; 36(46):6359-6373. PubMed ID: 28745319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unphosphorylated HSP27 (HSPB1) regulates the translation initiation process via a direct association with eIF4E in osteoblasts.
    Kuroyanagi G; Tokuda H; Yamamoto N; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
    Int J Mol Med; 2015 Sep; 36(3):881-9. PubMed ID: 26151374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer.
    Rocchi P; So A; Kojima S; Signaevsky M; Beraldi E; Fazli L; Hurtado-Coll A; Yamanaka K; Gleave M
    Cancer Res; 2004 Sep; 64(18):6595-602. PubMed ID: 15374973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hallmarks of castration-resistant prostate cancers.
    Katsogiannou M; Ziouziou H; Karaki S; Andrieu C; Henry de Villeneuve M; Rocchi P
    Cancer Treat Rev; 2015 Jul; 41(7):588-97. PubMed ID: 25981454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro.
    Rocchi P; Jugpal P; So A; Sinneman S; Ettinger S; Fazli L; Nelson C; Gleave M
    BJU Int; 2006 Nov; 98(5):1082-9. PubMed ID: 16879439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of heat shock protein 27 on extravillous trophoblast differentiation and on eukaryotic translation initiation factor 4E expression.
    Sadeh-Mestechkin D; Epstein Shochet G; Pomeranz M; Fishman A; Drucker L; Biron-Shental T; Lishner M; Tartakover Matalon S
    Mol Hum Reprod; 2014 May; 20(5):422-32. PubMed ID: 24431103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chaperone hsp27 inhibits translation during heat shock by binding eIF4G and facilitating dissociation of cap-initiation complexes.
    Cuesta R; Laroia G; Schneider RJ
    Genes Dev; 2000 Jun; 14(12):1460-70. PubMed ID: 10859165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.
    Zoubeidi A; Zardan A; Beraldi E; Fazli L; Sowery R; Rennie P; Nelson C; Gleave M
    Cancer Res; 2007 Nov; 67(21):10455-65. PubMed ID: 17974989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.
    Kiyama S; Morrison K; Zellweger T; Akbari M; Cox M; Yu D; Miyake H; Gleave ME
    Cancer Res; 2003 Jul; 63(13):3575-84. PubMed ID: 12839944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines.
    Ramamurthy VP; Ramalingam S; Gediya L; Kwegyir-Afful AK; Njar VC
    Oncotarget; 2015 Feb; 6(5):3195-210. PubMed ID: 25605250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer.
    Guan M; Fousek K; Chow WA
    FEBS J; 2012 Jul; 279(13):2399-411. PubMed ID: 22540830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atractylenolide I inhibits EMT and enhances the antitumor effect of cabozantinib in prostate cancer
    Qiao P; Tian Z
    Front Oncol; 2022; 12():1084884. PubMed ID: 36686743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.
    Ibuki N; Ghaffari M; Pandey M; Iu I; Fazli L; Kashiwagi M; Tojo H; Nakanishi O; Gleave ME; Cox ME
    Int J Cancer; 2013 Oct; 133(8):1955-66. PubMed ID: 23564295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer.
    Shiota M; Bishop JL; Nip KM; Zardan A; Takeuchi A; Cordonnier T; Beraldi E; Bazov J; Fazli L; Chi K; Gleave M; Zoubeidi A
    Cancer Res; 2013 May; 73(10):3109-19. PubMed ID: 23492367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.